Skip to content

PolitiKit

Stéphanie Michaud's lobbying: the registrations they file and every meeting they've reported since November 2021.

← Lobbying

Registrant (responsible officer)

Stéphanie Michaud

President and CEO

For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.

Meetings this Parliament
8
Since Nov 2021
8
Active registrations
1

Reported meetings

  • BioCanRx
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Kasondra White · Acting Director General, Innovation, Science and Economic Development Canada (ISED)
    Continued funding for BioCanRx's Immunotherapy Network from various government funding opportunities to derisk immunotherapies, support made-in-Canada biomanufacturing and clinical trials, and training in translational research and commercialization. Read more

    Official report

  • BioCanRx
    Continued funding for BioCanRx's Immunotherapy Network from various government funding opportunities to derisk immunotherapies, support made-in-Canada biomanufacturing and clinical trials, and training in translational research and commercialization. Read more

    Official report

  • BioCanRx
    • Paul Hébert · President, Canadian Institutes of Health Research (CIHR)
    • Jeff Moore · Associate Vice-President, Canadian Institutes of Health Research (CIHR)
    Continued funding for BioCanRx's Immunotherapy Network from various government funding opportunities to derisk immunotherapies, support made-in-Canada biomanufacturing and clinical trials, and training in translational research and commercialization. Read more

    Official report

  • BioCanRx
    • David MacFarlane · Director of Policy, Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Continued funding for BioCanRx's Immunotherapy Network from various government funding opportunities to derisk immunotherapies, support made-in-Canada biomanufacturing and clinical trials, and training in translational research and commercialization. Read more

    Official report

  • BioCanRx
    • Shahad Khalladi · Senior Policy Advisor, Health Canada (HC)
    Continued funding for BioCanRx's Immunotherapy Network from various government funding opportunities to derisk immunotherapies, support made-in-Canada biomanufacturing and clinical trials, and training in translational research and commercialization. Read more

    Official report

  • BioCanRx
    • Nipun Vats · ADM, Innovation, Science and Economic Development Canada (ISED)
    • Andrea Smith · A/Director General, Innovation, Science and Economic Development Canada (ISED)
    Continued funding for BioCanRx's Immunotherapy Network from various government funding opportunities to derisk immunotherapies, support made-in-Canada biomanufacturing and clinical trials, and training in translational research and commercialization. Read more

    Official report

  • BioCanRx
    • justine Frame · Policy Advisory, Health Canada (HC)
    • Jaeda Shilke · Regional Advisor, Health Canada (HC)
    Continued funding for BioCanRx's Immunotherapy Network from various government funding opportunities to derisk immunotherapies, support made-in-Canada biomanufacturing and clinical trials, and training in translational research and commercialization. Read more

    Official report

  • BioCanRx
    Continued funding for BioCanRx's Immunotherapy Network from various government funding opportunities to derisk immunotherapies, support made-in-Canada biomanufacturing and clinical trials, and training in translational research and commercialization. Read more

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.